Searchable abstracts of presentations at key conferences in endocrinology

ea0050p353 | Reproduction | SFEBES2017

Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes: a retrospective, observational study

Berni Thomas , Morgan Christopher , Berni Ellen , Rees Aled

Background: Polycystic ovary syndrome (PCOS) is characterised by hyperandrogenism, oligo/amenorrhoea and subfertility but the effects on mental health outcomes are unclear. Offspring neurodevelopment might also be influenced by gestational androgen exposure.Aims: To determine if (i) there is an association between PCOS and psychiatric outcomes, and (ii) rates of autism spectrum disorder (ASD) and attention deficit hyperactivity disorde...

ea0050p353 | Reproduction | SFEBES2017

Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes: a retrospective, observational study

Berni Thomas , Morgan Christopher , Berni Ellen , Rees Aled

Background: Polycystic ovary syndrome (PCOS) is characterised by hyperandrogenism, oligo/amenorrhoea and subfertility but the effects on mental health outcomes are unclear. Offspring neurodevelopment might also be influenced by gestational androgen exposure.Aims: To determine if (i) there is an association between PCOS and psychiatric outcomes, and (ii) rates of autism spectrum disorder (ASD) and attention deficit hyperactivity disorde...

ea0085p54 | Diabetes 2 | BSPED2022

Technology alone is not the answer for closing the deprivation gap in Type 1 Diabetes Mellitus (T1DM)

Sims Jack , Riddle Miles , Mitchell Thomas , Frerichs Carley

Introduction: Children and young people with T1DM living in the least deprived areas have better diabetes control vs those in most deprived areas with UK NPDA data suggesting that deprivation and ethnicity are associated with less use of technology.1Aims: 1. Review distribution of technology between different socio-economic and ethnic groups 2. To compare mean recent HbA1c results between groups using different combinations of technology<p...

ea0086p312 | Bone and Calcium | SFEBES2022

Hypercalcaemia in Renal Transplant Patients

Philip Kiserah , Gorrigan Rebecca , Randall David , Thurasingham Raj , Oates Thomas

Background: Hypercalcaemia is common in renal transplant recipients, the majority of whom have PTH-dependent hypercalcaemia due to tertiary hyperparathyroidism. PTH-independent hypercalcaemia is less common and is associated with significant, treatable underlying pathologies. In this study, we aimed to evaluate the prevalence and aetiology of PTH-independent hypercalcaemia in post-renal transplant patients.Method: This was a retrospective, single-centre ...

ea0086p121 | Reproductive Endocrinology | SFEBES2022

Tool development for the in vivo analysis of the physiological role of FSHR oligomerisation

Johnson Gillian , Hopkins Thomas , Agwuegbo Uche , Bousfield George , Jonas Kim

G protein-coupled receptors are the largest family of mammalian receptors, with key roles in controlling most physiological processes. Ovarian function is no exception, with a key ovarian GPCR, follicle stimulation hormone receptor (FSHR), and its endogenous ligand, FSH, critical for pre-antral-antral follicle growth and survival. An increasingly important way that GPCRs have been shown to regulate ligand specificity and signal amplitude is via association and formation of dim...

ea0068p11 | Abstracts | UKINETS2019

Can determination of radiological tumour volumes and tumour growth rates better determine response to somatostatin analogues in slowly growing neuroendocrine tumours?

Hazeldine Thomas , Braimah Fatimah , Brown Peter , Anthoney Alan

Introduction: Somatostatin analogues (SSA) are a cornerstone in the treatment of neuroendocrine tumours. Two clinical trials have defined the disease control effect of these treatments; the PROMID study of Octreotide LAR v’s placebo, median time to tumour progression (TTP) 14.2 m v’s 6.0 m, and the CLARINET study (Lanreotide v’s placebo), median progression free survival (PFS) 31 m v’s 18 m. In every day practice, however, many neuroendocrine tumours commen...

ea0065cc9 | FEATURED CLINICAL CASE POSTERS | SFEBES2019

A novel inherited epigenetic cause of pseudohypoparathyroidism type 1b

Crabtree Thomas , Dixit Abhijit , Johnson Katie , Chokkalingam Kamal

Pseudohypoparathyroidism type 1b (PHPT1b) is a rare disorder due to resistance to parathyroid hormone (PTH) and subsequent hypocalcaemia, hyperphosphataemia and normal or raised PTH levels. Sufferers usually present in childhood with seizures or tetany due to hypocalcaemia. Typically, PHPT1b is associated with defects on the long-arm of chromosome 20 in the form of uniparental (paternal) disomy of 20q or genetic mutations or sporadic epigenetic changes in GNAS gene. G...

ea0065p112 | Bone and calcium | SFEBES2019

Recurrence of hypercalcaemia more than ten years following parathyroidectomy, was it an unfortunate coincidence or should we routinely follow up high risk patients for a longer period following parathyroidectomy

Abdelrahim Siddig , Thomas Cecil , Hardy Robert , Lim Jonathan , Onyekwelu Emeka

Context: Parathyroid carcinoma is a very rare malignancy. It arises as a separate structure rather than from a pre-existing parathyroid adenoma. It may be difficult to differentiate it from parathyroid adenoma based on histology. When evaluating primary hyperparathyroidism clinical correlation should be taken into account. Clinical features of parathyroid carcinoma may include male gender, palpable neck nodule and higher parathyroid hormone and serum calcium levels associated ...

ea0065p200 | Metabolism and Obesity | SFEBES2019

A role for kisspeptin in long-term islet function in females

Smith Lorna , Hill Thomas , Simpson Sian , Jones Peter , Bowe James

Although characterised predominantly for its role in the brain, the neuropeptide kisspeptin has previously been shown to potentiate glucose-stimulated insulin through its receptor, GPR54; expressed abundantly in β-cells. We have previously reported a physiological role for kisspeptin signalling in the islet adaptation to pregnancy, using a β-cell specific GPR54 knockout mouse line (βGPR54ko). The aim of the present study was to examine the effects of impaired &#...

ea0065p353 | Reproductive Endocrinology and Biology | SFEBES2019

Differential expression in granulosa-lutein (GL) cells from polycystic ovaries of genes implicated in assembly and modification of extracellular matrix (ECM)

Hardy Kate , Hopkins Thomas , Lerner Avigdor , Green Orla , Franks Stephen

Introduction: Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder in women and polycystic ovaries are characterized by excess ovarian stroma that has implications for disordered follicle development in PCOS. The factors contributing to proliferation and increased density of stroma remain unclear but local overproduction of androgens may be involved.Aim: To examine differential expression of genes that regulate key proteins that comprise ...